Our network has expanded. PCRN have joined us and rebranded to Momentum Clinical Research.
- Home
- Clinical Trials
Cardiovascular Disease Study Sydney DH 2022
Cardiovascular Disease Study
Darlinghurst Sydney
Please note that this study has now closed. However, we encourage you to pre-register your interest for future Cardiovascular studies here.
Description
What to expect
Study details
Ages
45 years or older
Duration
Up to 5 years and will include both in-clinic visits and telephone follow-ups
Compensation
Participants will be reimbursed for reasonable expenses associated with study visits
Eligibility Criteria
You may qualify for this study if you:
- Are 45 years or older
- Have a body mass index (BMI) of 27 or higher
- Have a history of cardiovascular disease – such as a prior heart attack, stroke or narrowed arteries
This study may not be right for you if you:
- Have had a recent heart attack, stroke, or heart surgery (within the past 60 days)
- Have type 1 diabetes, advanced kidney disease, or certain other serious medical conditions
Other eligibility criteria will apply.
This study will be conducted at Momentum Darlinghurst
Locations
Description
Cardiovascular disease is a chronic condition that affects the heart, blood vessels and overall health. The disease is serious and widespread, making everyday life more difficult for many people – causing fatigue, shortness of breath, chest pain and increased risk of heart attacks or strokes.
Excess weight places extra strain on the heart and contributes to inflammation and other risk factors. Over time, this can lead to lasting damage and reduced quality of life. Cardiovascular disease remains the leading cause of death globally, and obesity rates continue to rise at an alarming rate.
Current treatments often focus on managing symptoms, through medications and lifestyle changes - but many people still face a high risk of future heart problems.
This study is exploring a new treatment approach that aims to improve heart health, reduce cardiovascular events, and support sustained weight loss - potentially leading to better long-term outcomes and quality of life.
What to expect
The treatment works by targeting specific hormones in the body that regulates appetite, metabolism and inflammation - all of which are closely linked to heart health and obesity.
Participants will receive a monthly injection, with the dose gradually increased over time to support comfort and tolerability. During the time of the study, you will visit the clinic regularly and our medical team will monitor your health.
The goal is to not only support meaningful, sustained weight loss, but also improve heart health and overall quality of life.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future Cardiovascular studies here.